Epstein-Barr Virus EBV Has Targetable Sites Monoclonal Antibodies Can Attack To Provide Protection Against the Infection Medicine & Technology Oct 28, 2022 An experiment on monoclonal antibodies targeting different sites of the Epstein-Barr virus (EBV) provided nearly complete protection against the infection and lymphoma in mice. Read the article to learn more details.
Exotic Particle X(2370) Made of Pure Force Could Be Lightest Glueball Predicted by Standard Model of Physics
Prehistoric Global Warming Caused by Massive Volcanic Eruption Turned Dinosaurs Into Warm-Blooded Animals
SPACE NASA Releases High-Definition Photos of Jupiter’s Moon Europa With Complex Surface Features Called ‘The Platypus’
SPACE James Webb Space Telescope Finds Most Distant Pair of Colliding Black Holes, Raising Questions Regarding Theories of Cosmology
SPACE Don Pettit, Oldest Active NASA Astronaut, Gears Up for New Mission to the International Space Station
SPACE Massive X8.7 Solar Flare From Super-Active Sunspot Causes Radio Blackouts Over North, South America Days After Widespread Aurora Displays